News Focus
News Focus
icon url

PonkenPlonken

07/09/24 12:40 PM

#169 RE: Monksdream #168

LLYs Prevail dropped deal with Precision in Duchenne in April. Prevail, on their website, pretty much now mentions the superiority of SLDBs AAV approach. SLDB would perfectly fit into LLY/Prevails pipeline as their product trumps that of Precision...... and we know that they are looking for something in Duchenne. I actually believe they dropped the Prevail/Precision partnership after they saw what SLDB can do.

https://www.fiercebiotech.com/biotech/lillys-prevail-walks-away-gene-editing-collab-precision
https://www.prevailtherapeutics.com/programs/#our-pipeline
https://www.prevailtherapeutics.com/our-science/#overview